Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells

BACKGROUND: Metformin is an approved drug prescribed for diabetes. Its role as an anti-cancer agent has drawn significant attention because of its minimal side effects and low cost. However, its mechanism of anti-tumour action has not yet been fully clarified. METHODS: The effect on cell growth was...

Descripción completa

Detalles Bibliográficos
Autores principales: Demir, Ummuhan, Koehler, Andrea, Schneider, Rainer, Schweiger, Susann, Klocker, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929757/
https://www.ncbi.nlm.nih.gov/pubmed/24484909
http://dx.doi.org/10.1186/1471-2407-14-52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929757/
https://www.ncbi.nlm.nih.gov/pubmed/24484909
http://dx.doi.org/10.1186/1471-2407-14-52

Ejemplares similares